Herndon Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-26
Closed -$2K 618
2016
Q3
$2K Hold
26
﹤0.01% 412
2016
Q2
$2K Buy
+26
New +$1.85K ﹤0.01% 428
2016
Q1
Sell
-700
Closed -$43K 218
2015
Q4
$43K Buy
700
+528
+307% +$33.3K ﹤0.01% 166
2015
Q3
$11K Buy
+172
New +$12.3K ﹤0.01% 173
2013
Q3
Sell
-1,476,869
Closed -$67.4M 197
2013
Q2
$67.4M Buy
+1,476,869
New +$64M 1% 47

Other funds holding STJ

Herndon Capital Management's STJ Position: Q4 2016 in Review

Herndon Capital Management sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 26 shares — an estimated $2K sold.

Herndon Capital Management first reported a position in STJ in Q2 2013 and held it in 5 quarters. The position peaked at $67.4M in Q2 2013. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Herndon Capital Management reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Herndon Capital Management sold 26 St Jude Medical shares in Q4 2016, an estimated $2K.
  • Herndon Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 5 quarters.
  • Herndon Capital Management's St Jude Medical position peaked at $67.4M in Q2 2013.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Herndon Capital Management's 13F filing for Q4 2016, filed 2 Feb 2017.